Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - furosemide, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; sodium chloride - oedema: furosemide-baxter injection is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. furosemide-baxter injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous route. parenteral use should be replaced with oral frusemide as soon as practical.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - furosemide, quantity: 20 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - oedema: furosemide-baxter injection is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. furosemide-baxter injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous route. parenteral use should be replaced with oral frusemide as soon as practical.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

edcl (bogra) - frusemide - tablet - 40 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

edcl (dhaka) - frusemide - tablet - 40 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

edcl (dhaka) - frusemide - injection - 20 mg/2 ml

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

medopharm, india - frusemide - tablets - 40 mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

elys chemical industries limited, kenya - frusemide - tablets - 40

Kenya - English - Pharmacy and Poisons Board

laboratoire renaudin za errobi 64250 itxassou france - frusemide inj. 20mg/2ml - solution for injection - 1 ml solution for injection contains 10mg of… - high-ceiling diuretics: plain sulfonamides

Kenya - English - Pharmacy and Poisons Board

elys chemical industries ltd po box 40411-oo100 nairobi - frusemide bp - tablet - 40 mg / tablet - antianemic preparations - iron preparations: iron

Ireland - English - HPRA (Health Products Regulatory Authority)

napp pharmaceuticals limited - furosemide potassium chloride - tablets - 40mg, 600m %v/v